DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters adminstered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

Journal of Biochemical and Molecular Toxicology

Volumn 15, Issue 1, 2001, Pages 26-33

  Fretland, Adrian J ^a   Devanaboyina, Uday S ^a   Nangju, Norma A ^a   Leff, Matthew A ^a   Xiao, Gong H ^a   Webb, Stephanie J ^a   Doll, Mark A ^a   Hein, David W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

2 amino 1 methyl1 6phenylimidazo 4,5 b pyridine; Acetylation polymorphism, DNA adducts; Mammarycancer; PHIP; Syrian hamster

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ACYLTRANSFERASE; CARCINOGEN; DNA; FAT; SULFOTRANSFERASE;

ACETYLATION; ACETYLATOR PHENOTYPE; ANIMAL TISSUE; ARTICLE; BREAST; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CATALYSIS; COLON; CONTROLLED STUDY; DNA ADDUCT; ENVIRONMENT; EPIDEMIOLOGY; EPITHELIUM CELL; EXPOSURE; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEART; HUMAN; LIPID DIET; LIVER; METABOLIC ACTIVATION; NONHUMAN; PANCREAS; RAT; REGULATORY MECHANISM; SMALL INTESTINE; SYRIAN HAMSTER;

ACETYLATION; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, CONGENIC; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; CRICETINAE; DISEASE MODELS, ANIMAL; DNA ADDUCTS; FEMALE; HOMOZYGOTE; IMIDAZOLES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MESOCRICETUS; TISSUE DISTRIBUTION;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 0035145351     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0461(2001)15:1<26::AID-JBT3>3.0.CO;2-S     Document Type: Article

References (59)

1. Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research
2. A new colon and mammary carcinogen in cooked food, 2-amino-l-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)
3. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) carcinogenicity in rats
4. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) derived from cooked foods
5. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat
6. Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets
7. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high temperature-cooked meat, and breast cancer risk
8. Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites
9. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues
10. Possible mechanisms for PhIP-DNA adduct formation in mammary gland of female Sprague-Dawley rats
11. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
12. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice
13. Identification of N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6- phenylimidazo [4,5-b]pyridine as the major adduct formed by the food- borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA
14. Specific 5′-GGGA-3′->5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
15. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
16. Preferential induction of guanine deletion of 5′-GGGA-3′ in rat mammary glands by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
17. Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
18. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
19. Purification of hepatic polymorphic arylamine N-acetyl-transferase from homozygous rapid acetylator inbred hamster: Identity with polymorphic N-hydroxyarylamine O-acetyltransferase
20. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): Acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens
21. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyl-transferase (NAT2) in colon cytosols of Syrian locus
22. Rodent models of the human acetylation polymorphism: Comparisons of recombinant acetyltransferases
23. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
24. Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic hamsters
25. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster
26. A new model for toxic risk assessments: Construction of homozygous rapid and slow acetylator congenic Syrian hamster lines
27. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus
28. Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus
29. Novel human N-acetyltransferase 2 (NAT2) alleles that differ in mechanism for slow acetylator phenotype
30. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than Wistar Kyoto (slow) acetylator inbred rats
31. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse
32. 3,2′-Dimethyl-4-aminobiphenyl-DNA adduct formation in tumor target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus
33. DNA adduct levels and intestinal lesions in congenic rapid and slow acetylator Syrian hamsters administered the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)
34. Pancreatic DNA adducts formed in vitro and in vivo by the food mutagens 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) and 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC)
35. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5-f]quinoline by dietary indole-3-carbinol in female rats
36. Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats
37. Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA
38. Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters
39. Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl
40. Effect of acetylator genotype on 3,2′-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamsters
41. Carcinogenicity of 3-methyl-2-naphthylamine and 3,2′-dimethyl-4-aminobiphenyl to the bladder and gastrointestinal tract of the Syrian golden hamster with atypical proliferative enteritis
42. Colon and urinary bladder tumorigenesis in homozygous rapid and slow acetylator (NAT2) congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl
43. Induction of intestinal, mammary, and ovarian tumors in hamsters with oral administration of 20-methylcholanthrene
44. Background data on tumor incidence in control animals (Syrian hamsters)
45. Urinary bladder and liver cell tumors induced in hamsters with o-aminoazotoluene
46. Multipotential carcinogenesis with urethan in the Syrian golden hamster
47. Mammary carcinogenesis in the hamster
48. The induction of maligant lymphomas and other tumours by 7,12-dimethylbenz(a)anthracene in the Syrian golden hamster
49. Methylcholanthrene-induced metastatic mammary carcinoma in several inbred hamster strains
50. The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice, and hamsters
51. The binding of 7,12-dimethylbenz[a]anthracene to mammary gland macromolecules in the hamster: Effects of enovid feeding or transplacental exposure to diethylstilboestrol
52. Metabolism of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in isolated liver cells from guinea pig, hamster, mouse, and rat
53. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk for colorectal cancer or polyps
54. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer
55. Well-done meat intake and the risk of breast cancer
56. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk
57. N-acetyltransferase-2 genetic polymorphism, well-done meat intake and breast cancer risk among postmenopausal women
58. Dietary heterocyclic amines and cancer of the colon, rectum, bladder and kidney: A population-based study
59. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype